يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Langley, Richard"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

    المؤلفون: Papp, Kim A.1 kapapp@probitymedical.com, Langley, Richard G.2, Lebwohl, Mark3, Krueger, Gerald G.4, Szopary, Philippe5, Yeilding, Newman5, Guzzo, Cynthia5, Hsu, Ming-Chun5, Yuhua Wang5, Shu Li5, Dooley, Lisa T.5, Reich, Kristian6

    المصدر: Lancet. 5/17/2008, Vol. 371 Issue 9625, p1675-1684. 10p. 3 Color Photographs.

    مصطلحات موضوعية: SKIN diseases, MONOCLONAL antibodies, THERAPEUTICS research, DRUG efficacy, PSORIASIS treatment, SKIN inflammation, PATIENTS


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial.

    المؤلفون: Reich, Kristian1,2 (AUTHOR) k.reich@uke.de, Armstrong, April W3 (AUTHOR), Langley, Richard G4 (AUTHOR), Flavin, Susan5 (AUTHOR), Randazzo, Bruce5 (AUTHOR), Li, Shu5 (AUTHOR), Hsu, Ming-Chun5 (AUTHOR), Branigan, Patrick5 (AUTHOR), Blauvelt, Andrew6 (AUTHOR)

    المصدر: Lancet. Sep2019, Vol. 394 Issue 10201, p831-839. 9p.


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Cutaneous larva migrans.

    المؤلفون: Purdy, Kern S.1, Langley, Richard G.1, Webb, Amanda N.2, Walsh, Noreen3, Haldane, David4

    المصدر: Lancet. 6/4/2011, Vol. 377 Issue 9781, p1948-1948. 1p.

    مصطلحات موضوعية: VISCERAL larva migrans, ANCYLOSTOMATIDAE


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial.

    المؤلفون: Reich, Kristian1 (AUTHOR), Papp, Kim A2 (AUTHOR), Blauvelt, Andrew3 (AUTHOR), Langley, Richard G4 (AUTHOR), Armstrong, April5 (AUTHOR), Warren, Richard B6 (AUTHOR), Gordon, Kenneth B7 (AUTHOR), Merola, Joseph F8 (AUTHOR), Okubo, Yukari9 (AUTHOR), Madden, Cynthia10 (AUTHOR), Wang, Maggie10 (AUTHOR), Cioffi, Christopher10 (AUTHOR), Vanvoorden, Veerle11 (AUTHOR), Lebwohl, Mark12 (AUTHOR)

    المصدر: Lancet. 2/6/2021, Vol. 397 Issue 10273, p487-498. 12p.

    مصطلحات موضوعية: *DRUG efficacy, *BODY surface area, *PLACEBOS, *PSORIASIS, *COMPARATOR circuits, *GINGIVITIS, *THERAPEUTIC use of monoclonal antibodies, *RESEARCH, *RESEARCH methodology, *MEDICAL cooperation, *EVALUATION research, *COMPARATIVE studies, *BLIND experiment, *DERMATOLOGIC agents

    الشركة/الكيان: UCB SA 043546522


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial.

    المؤلفون: Papp, Kim1 kapapp@probitymedical.com, Cather, Jennifer C.2, Rosoph, Les3, Sofen, Howard4, Langley, Richard G.5, Matheson, Robert T.6, Chia Chi Hu7, Day, Robert M.7

    المصدر: Lancet. 8/25/2012, Vol. 380 Issue 9843, p738-746. 9p.

    مصطلحات موضوعية: *CHEMICAL inhibitors, *PHOSPHODIESTERASES, *INFLAMMATORY mediators, *PSORIASIS, *PLACEBOS, *RANDOMIZED controlled trials


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث